RAP 0.00% 20.5¢ raptor resources limited

Ann: Publication on challenges of diagnosing respiratory disease, page-25

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 27,363 Posts.
    lightbulb Created with Sketch. 1776
    $300M MC will be very conservative given the massive revenue potential of both acute respiratory disease and chronic respiratory management for COPD and Asthma.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.